AI-Discovered Drug Reverses Aging Markers In Study, Biotech Says - Bloomberg.com

• • Insilico Medicine used AI to design rentosertib, a drug for idiopathic pulmonary fibrosis.


• • Phase 2a clinical trials showed a reduction in biological age markers across six different proteomic clocks.


• • Results suggest patients appeared 3 to 6 years younger biologically, though the study was small and exploratory.

Context
The drug was originally intended to treat lung fibrosis rather than aging itself. Researchers used blood protein data to measure how the treatment influenced biological aging markers.

Christian Perspective
While extending life can be a way to serve God and family longer, attempting to reverse aging can border on the sin of pride and the desire to play God. We must distinguish between healing the sick and the transhumanist pursuit of escaping the natural mortality ordained by the Creator. True vitality comes from spiritual strength and living according to the natural order.

Implications
If these technologies become mainstream, they may create a biological divide where only the globalist elite can afford to extend their lives. This could lead to a permanent ruling class that uses life extension to maintain power and control over the masses. Such a development threatens the traditional cycle of generations and the natural passing of leadership.

Broader Trends
This reflects a growing reliance on secular, AI-driven solutions to solve fundamental human conditions. It aligns with a broader movement toward transhumanism that seeks to use technology to override biological realities. This trend often serves the interests of massive biotech corporations and the technocratic elites who manage them.

Takeaway
Americans should remain skeptical of technological promises that aim to subvert the natural order of life and death. We must prioritize the health of the family and the strength of the nation over the pursuit of artificial longevity. Focus on God-given biological health and the preservation of our heritage rather than the promises of silicon-based salvation.